bioAffinity Technologies Set for Continued Expansion in 2025
bioAffinity Technologies, Inc. (BIAF)
Company Research
Source: Business Wire
Noninvasive CyPath® Lung test for lung cancer contributes to growing revenues SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today reported that the successful execution of its pilot marketing program and steady growth in sales of the CyPath® Lung test for early detection of lung cancers have set the stage for expansion and record revenues in 2025.The Company’s wholly owned subsidiary Precision Pathology Laboratory Services (PPLS) is on track to report upwards of $9.4 million in 2024 revenues, more than 20% growth in annualized revenues over 2023 after accounting for the acquisition of PPLS in September 2023. The increase in revenues reflects a 1,750% increase in sales of CyPath® Lung through Nov. 30, compared to the same period last year.“The seamless integration of Precision Pathology into bioAffinity Technologies since the acquisition is
Show less
Read more
Impact Snapshot
Event Time:
BIAF
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIAF alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIAF alerts
High impacting bioAffinity Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
BIAF
News
- Join bioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19 [Yahoo! Finance]Yahoo! Finance
- Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19Business Wire
- bioAffinity Technologies Set for Continued Expansion in 2025 [Yahoo! Finance]Yahoo! Finance
- Veterans' Research Foundation Spotlights CyPath® Lung's Addition to the Federal Supply Schedule [Yahoo! Finance]Yahoo! Finance
- Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply ScheduleBusiness Wire
BIAF
Sec Filings
- 12/23/24 - Form 8-K
- 12/20/24 - Form 8-K
- 12/9/24 - Form 424B3
- BIAF's page on the SEC website